Market
What will be the main application areas of FLUID framework in biomedical research by 2025?
2
Resolution / Starting Odds
Cancer Research • 25%
Neuroscience • 25%
Cardiovascular Studies • 25%
Other • 25%
Official reports or publications from NASA or partner organizations
Story
FLUID Framework Enables Federated Learning for Biomedical AI Between Earth and ISS Using Real and Synthetic Data
Jan 19, 2025, 05:51 PM
A new framework named FLUID (Federated Learning Using In-space Data) has been developed to enable federated learning for training biomedical machine learning models in a spaceflight context. This foundational architecture facilitates the training and updating of classifier models between Earth and the International Space Station (ISS) using both real biomedical research data and synthetically generated data. The initiative represents a significant advancement in the application of AI technologies in space, allowing for decentralized data training without the need for centralized data storage.
View original story
Similar markets
Neurodegenerative diseases • 25%
Stem cell therapy • 25%
Cancer research • 25%
Longevity research • 25%
Improved research quality • 25%
Increased efficiency • 25%
Cost reduction • 25%
Broader access to research tools • 25%
Disease prevention • 25%
Anti-aging treatments • 25%
Other • 25%
Cellular rejuvenation • 25%
Autoimmune diseases • 25%
Cancer treatment • 25%
Viral infections • 25%
Bacterial infections • 25%
Genetic modification • 25%
Organ regeneration • 25%
Other • 25%
Neural enhancement • 25%
Cryptography • 25%
Other • 25%
Drug Discovery • 25%
AI and Machine Learning • 25%
Other applications • 25%
Drone defense • 25%
Missile interception • 25%
Ground target engagement • 25%
Data Analysis • 25%
Content Creation • 25%
Customer Service • 25%
Other • 25%
Customer Service • 25%
Healthcare • 25%
Education • 25%
Entertainment • 25%
Sensory perception studies • 25%
Other • 25%
Drug testing and effects • 25%
Cognitive studies in mice • 25%
Cybersecurity advancements • 25%
Public adoption strategies • 25%
Regulatory impact analysis • 25%
Digital currency transaction efficiency • 25%
Other • 25%
Neuroscience • 25%
Genetic Diseases • 25%
Cancer Research • 25%